Biotech Mission Therapeutics awarded $5.2m from The Michael J. Fox Foundation and Parkinson’s UK to advance potential disease-modifying treatment MTX325 July 2, 2024
Biotech Sobi initiates rolling biologics license application to FDA for SEL-212 for the potential treatment of chronic refractory gout July 2, 2024
Biotech BrainStorm Cell Therapeutics to Provide Corporate Mid-Year Update on NurOwn Program July 1, 2024
Biotech IASO Bio Presented Clinical Data and Single-cell Analysis of Equecabtagene Autoleucel for the Treatment of Central Nervous System Autoimmunity in Oral Presentation at EAN Congress 2024 July 1, 2024
Biotech SCG Cell Therapy Announces FDA IND Clearance of SCG142, a next-generation HPV-specific TCR T cell therapy for patients with HPV-associated solid tumors July 1, 2024
Biotech Protein Expression Market size is set to grow by USD 3.40 billion from 2024-2028, Increasing advances in proteomics research boost the market, Technavio June 29, 2024
Biotech Nipocalimab pivotal Phase 3 trial demonstrates longest sustained disease control in FcRn class for broadest population of myasthenia gravis patients June 29, 2024
Search
Biotech
July 2, 2024
July 2, 2024
July 2, 2024
July 1, 2024
July 1, 2024
July 1, 2024
July 1, 2024
June 29, 2024
June 29, 2024
June 29, 2024
